Nakazawa Hayato, Okimoto Kenichiro, Matsumura Tomoaki, Yokoyama Masayuki, Ishikawa Tsubasa, Fukuda Yoshihiro, Kitsukawa Yoshio, Kurosugi Akane, Sonoda Michiko, Kaneko Tatsuya, Ohta Yuki, Taida Takashi, Matsusaka Keisuke, Ikeda Jun-Ichiro, Kato Jun
Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Gastroenterology, Chiba University, Inohana, 1-8-1, Chiba 260-8670, Japan.
Therap Adv Gastroenterol. 2025 Jul 20;18:17562848251356112. doi: 10.1177/17562848251356112. eCollection 2025.
There is insufficient evidence regarding the management of hematochezia after colorectal endoscopic mucosal resection (EMR) without endoscopic hemostasis.
The aim of this study was to develop an observable score for hematochezia after colorectal EMR.
Retrospective study.
This retrospective study included three hospitals in Japan. During the study period, colorectal EMR was performed in 3989 patients (11,414 lesions). Post-EMR hematochezia (delayed bleeding (DB)) was observed in 169 patients (512 lesions). Of these, 47 patients (150 lesions) were classified into the Hemostasis Group, comprising those who underwent endoscopic hemostasis. The remaining 122 (362 lesions) were classified into the non-hemostasis group, comprising those who underwent endoscopy without hemostasis, received preventive hemostasis, and did not undergo emergency endoscopy. Weighted points were assigned to predict observable cases following colorectal EMR through multivariate logistic regression analysis, enabling the development of a predictive model.
The prediction model comprised three variables (male gender, American Society of Anesthesiologists Physical Status 3, direct oral anticoagulant). According to the definition, the total score was categorized as lowly observable (2 or 3 points) and highly observable (0 or 1 points) for DB after colorectal EMR. As a result, the rates of observable cases for each risk category were 45.7% and 81.8%, respectively. The model showed good discrimination ability from the c-statistic (95% CI) of 0.71 (0.63-0.79).
Although further prospective studies are necessary to validate the utility of the score, it may be useful in clinical practice.
关于结直肠内镜黏膜切除术(EMR)后未行内镜止血的便血处理,证据不足。
本研究旨在建立一种用于结直肠EMR后便血的可观察评分系统。
回顾性研究。
这项回顾性研究纳入了日本的三家医院。在研究期间,对3989例患者(11414处病变)进行了结直肠EMR。169例患者(512处病变)观察到EMR后便血(延迟出血[DB])。其中,47例患者(150处病变)被归类为止血组,包括那些接受内镜止血的患者。其余122例(362处病变)被归类为非止血组,包括那些接受了无止血的内镜检查、预防性止血且未接受急诊内镜检查的患者。通过多因素逻辑回归分析为预测结直肠EMR后的可观察病例分配加权分数,从而建立预测模型。
预测模型包括三个变量(男性、美国麻醉医师协会身体状况3级、直接口服抗凝剂)。根据定义,总分被分类为结直肠EMR后DB的低可观察性(2或3分)和高可观察性(0或1分)。结果,每个风险类别的可观察病例发生率分别为45.7%和81.8%。该模型从c统计量(95%CI)为0.71(0.63 - 0.79)显示出良好的区分能力。
尽管需要进一步的前瞻性研究来验证该评分的实用性,但它在临床实践中可能有用。